Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes

Hendawy Om1, Mehrez E El-Naggar2, Mona El-Banna3

  • 1Faculty of Pharmacy, Jouf University, Saudi Arabia-Lecturer of Clinical Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.

Investigational New Drugs
|February 13, 2020
PubMed
Summary

This study developed Diosmin nanoparticles (DSN-NPs) using hydroxypropyl starch (HPS) and Poly lactide-glycolide-chitin (PLGA/chitin) to improve bioavailability for treating diabetic atherosclerosis. DSN-NPs, particularly PLGA/chitin, effectively counteracted diabetes-induced atherosclerosis factors.